|
HY-P1205A-10mg
|
MedChemexpress LLC
|
MCH(human, mouse, rat) (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1205A-5mg
|
MedChemexpress LLC
|
MCH(human, mouse, rat) (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13259-10mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-100mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-200mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-25mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-5mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-50mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-500mg
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-13259-1mL
|
MedChemexpress LLC
|
MG-132 [CAS 133407-82-6] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-112606-10mg
|
MedChemexpress LLC
|
ML-290 [CAS 1482500-76-4]
|
|
|
|
|
HY-112606-100mg
|
MedChemexpress LLC
|
ML-290 [CAS 1482500-76-4]
|
|
|
|
|
HY-112606-5mg
|
MedChemexpress LLC
|
ML-290 [CAS 1482500-76-4]
|
|
|
|
|
HY-112606-50mg
|
MedChemexpress LLC
|
ML-290 [CAS 1482500-76-4]
|
|
|
|
|
HY-112606-1mL
|
MedChemexpress LLC
|
ML-290 [CAS 1482500-76-4] (10mM in DMSO)
|
|
|
|
|
HY-P1029-1mg
|
MedChemexpress LLC
|
MLCK inhibitor peptide 18 [CAS 224579-74-2]
|
|
|
|
|
HY-P1029-10mg
|
MedChemexpress LLC
|
MLCK inhibitor peptide 18 [CAS 224579-74-2]
|
|
|
|
|
HY-P1029-25mg
|
MedChemexpress LLC
|
MLCK inhibitor peptide 18 [CAS 224579-74-2]
|
|
|
|
|
HY-P1029-5mg
|
MedChemexpress LLC
|
MLCK inhibitor peptide 18 [CAS 224579-74-2]
|
|
|
|
|
HY-12220A-10mg
|
MedChemexpress LLC
|
MM-102 (TFA) [CAS 1883545-52-5]
|
|
Cancer-programmed cell death
|
|
|
HY-12220A-2mg
|
MedChemexpress LLC
|
MM-102 (TFA) [CAS 1883545-52-5]
|
|
Cancer-programmed cell death
|
|
|
HY-12220A-5mg
|
MedChemexpress LLC
|
MM-102 (TFA) [CAS 1883545-52-5]
|
|
Cancer-programmed cell death
|
|
|
HY-12220A-50mg
|
MedChemexpress LLC
|
MM-102 (TFA) [CAS 1883545-52-5]
|
|
Cancer-programmed cell death
|
|
|
HY-12220A-1mL
|
MedChemexpress LLC
|
MM-102 (TFA) [CAS 1883545-52-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1117-1mg
|
MedChemexpress LLC
|
MMK1 [CAS 271246-66-3]
|
|
COVID-19-immunoregulation
|
|
